Upturn unsubscribed user
$1.14/ day, billed weekly
Cancel anytime
(Ad-Free, Unlimited access)​
NO CREDIT CARD REQUIRED
VHAQ
Upturn stock ratingUpturn stock rating

Viveon Health Acquisition Corp (VHAQ)

Upturn stock ratingUpturn stock rating
$10
Delayed price
upturn advisory
PASS
  • BUY Advisory
  • SELL Advisory (Profit)​
  • SELL Advisory (Loss)​
  • Profit
  • Loss
  • Pass (Skip investing)
Upturn Stock infoUpturn Stock info Stock price based on last close
*as per simulation
(see disclosures)
Time period over
  • ALL
  • YEAR
  • MONTH
  • WEEK

Upturn Advisory Summary

01/30/2025: VHAQ (1-star) is currently NOT-A-BUY. Pass it for now.

Upturn Star Rating

ratingratingratingratingrating

Not Recommended Performance

These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.

AI Based Fundamental Rating

ratingratingratingratingrating

Above Average Performance

These Stocks/ETFs, based on Upturn Advisory, frequently surpass the market, reflecting reliable and trustworthy advice.

Analysis of Past Performance

Type Stock
Historic Profit -14.22%
Avg. Invested days 88
Today’s Advisory PASS
Upturn Star Rating Upturn stock ratingUpturn stock rating
Upturn Advisory Performance Upturn Advisory Performance 4.0
Stock Returns Performance Upturn Returns Performance 1.0
Upturn Profits based on simulationUpturn Profits based on simulation Profits based on simulation
Upturn Profits based on simulationUpturn Profits based on simulation Last Close 01/30/2025

Key Highlights

Company Size Small-Cap Stock
Market Capitalization 66.49M USD
Price to earnings Ratio -
1Y Target Price -
Price to earnings Ratio -
1Y Target Price -
Volume (30-day avg) -
Beta -0.11
52 Weeks Range 0.00 - 11.00
Updated Date 02/28/2025
52 Weeks Range 0.00 - 11.00
Updated Date 02/28/2025
Dividends yield (FY) -
Basic EPS (TTM) -0.04

Earnings Date

Report Date -
When -
Estimate -
Actual -

Profitability

Profit Margin -
Operating Margin (TTM) -

Management Effectiveness

Return on Assets (TTM) -3.25%
Return on Equity (TTM) -

Valuation

Trailing PE -
Forward PE -
Enterprise Value 70541803
Price to Sales(TTM) -
Enterprise Value 70541803
Price to Sales(TTM) -
Enterprise Value to Revenue -
Enterprise Value to EBITDA 21.91
Shares Outstanding 6648660
Shares Floating 651929
Shares Outstanding 6648660
Shares Floating 651929
Percent Insiders 88.47
Percent Institutions 13.38

Analyst Ratings

Rating -
Target Price -
Buy -
Strong Buy -
Buy -
Strong Buy -
Hold -
Sell -
Strong Sell -
Strong Sell -

Upturn AI SWOT

Viveon Health Acquisition Corp.: An In-Depth Analysis

Company Profile:

History and Background: Viveon Health Acquisition Corp. (NASDAQ: VHC) is a blank check company incorporated in Delaware on February 26, 2021. The company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. As of November 2023, Viveon has not yet completed an initial business combination.

Core Business Areas: Viveon seeks to identify and acquire healthcare businesses, with an emphasis on the pharmaceutical industry. The company focuses on businesses in the commercial stage with revenue, profitability, and a strong market position.

Leadership Team:

  • Chairman & Chief Executive Officer: John Bonfiglio
  • President: Matthew Pauls
  • Chief Financial Officer: David Smith
  • Director and Advisor to CEO: John O'Neill Jr.

Corporate Structure: Viveon operates as a Delaware corporation with an executive team based in the United States.

Top Products and Market Share:

Products & Offerings: As a blank check company, Viveon doesn't currently have its own products or market share.

Financial Performance:

Revenue & Net Income: Viveon has not yet generated any revenue, as they haven't completed a business combination. Net income is also unavailable due to the lack of operations.

Profit Margins: Unavailable at present.

Earnings per Share (EPS): Unavailable at this time.

Financial Analysis: Due to the company's current stage, a complete financial analysis is not feasible.

Dividends and Shareholder Returns:

Dividend History: Viveon has not paid any dividends to date.

Shareholder Returns: As the company has yet to complete a merger and commence operations, shareholder return data is not available.

Growth Trajectory:

Historical Growth: Due to Viveon's status as a pre-merger entity, historical growth data is unavailable.

Future Growth Projections: Future growth projections are highly speculative at this stage, as they depend heavily on the target company Viveon eventually chooses to acquire.

Market Dynamics:

The healthcare industry is constantly evolving, with advancements in technology, changing demographics, and increased government regulation all shaping its future. Viveon, once it completes an acquisition, will have to navigate this complex landscape.

Competitors:

Key competitors in the blank check company space, along with their stock ticker symbols, include:

  • Cassava Science (SAVA)
  • Medical Properties Trust (MPW)
  • Digital World Acquisition Corp. (DWAC)
  • Xometry Inc. (XMTR)
  • Molecular Templates, Inc. (MTEM)

Potential Challenges and Opportunities:

Key Challenges:

  • Identifying a suitable target company to acquire.
  • Successfully completing an initial business combination.
  • Integrating the acquired business and creating value for shareholders.
  • Successfully navigating the complexities of the healthcare market.

Potential Opportunities:

  • Acquiring a business with strong growth potential and synergies with existing operations.
  • Leveraging the expertise and resources of its management team to drive future growth and success.
  • Utilizing its public listing to access capital for potential acquisitions and growth initiatives.

Recent Acquisitions:

As Viveon has not yet completed any acquisitions, this section is currently inapplicable.

AI-Based Fundamental Rating:

Rating: Due to Viveon's early-stage nature and limited publicly available data, providing a reliable AI-based fundamental rating is difficult.

Justification: An accurate AI model requires sufficient historical financial and operational data, which is unavailable for Viveon at this stage.

Sources and Disclaimers:

Conclusion

Viveon Health Acquisition Corp. presents a unique investment opportunity as it seeks to combine with an established healthcare entity. While it's crucial to consider potential challenges and opportunities, Viveon's leadership team and focus on the commercially established healthcare space suggest the potential for successful growth and value creation.

It's important to note that this report offers a preliminary analysis of Viveon based on available data. Performing additional research and due diligence are strongly advised before making any investment decisions.

Upturn AI SummarizationUpturn AI Summarization AI Summarization is directionally correct and might not be accurate.

Upturn AI SummarizationUpturn AI Summarization Summarized information shown could be a few years old and not current.

Upturn AI SummarizationUpturn AI Summarization Fundamental Rating based on AI could be based on old data.

Upturn AI SummarizationUpturn AI Summarization AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.

About Viveon Health Acquisition Corp

Exchange NYSE MKT
Headquaters Atlanta, GA, United States
IPO Launch date 2021-02-04
CEO, President & Chairman of the Board Dr. Jagi Gill M.D., Ph.D.
Sector Financial Services
Industry Shell Companies
Full time employees -
Website
Full time employees -
Website

Viveon Health Acquisition Corp. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization, or similar business combination with one or more businesses in the healthcare industry in North America. The company was incorporated in 2020 and is based in Atlanta, Georgia. Viveon Health Acquisition Corp. operates as a subsidiary of Viveon Health LLC.

Upturn is now on iOS and Android!

Experience Upturn on your mobile. Install it now!​